Power Law company profile

Poseida Therapeutics

Biotech & Life Sciences · San Diego, United States · Founded 2015 · IPO 2020 Unicorn

Poseida Therapeutics utilizes best-in-class genome engineering capabilities to develop targeted lifesaving therapeutics

Valuation

$500M–1B

Latest valuation · 2026

Unlock exact value

Revenue

$50–100M

Latest reported FY

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

11 investors on Poseida Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Malin Corporation

Series B+ 10 investors entered at this stage

Amblyotech

Aisling Capital

Adage Capital

Fidelity Investments

Novartis

Perceptive Advisors

Schonfeld Strategic Advisors

Longitude Capital

Vivo Capital

Boxer Capital

Global footprint

Where Poseida Therapeutics has talent and traffic

AI talent share

0.9% of workforce is AI talent
(1 of 116 staff)

Core AI00%

Other AI10.86%

Non-AI workforce11599.14%

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

Web traffic by country

3.8K monthly visits
across markets

🇺🇸 United States100%

Top 1 markets shown

Patent intelligence

$53M patent portfolio · 48 active families

Estimated portfolio value

$53M

6.8% of valuation · 38.1× smaller than top peer Ablynx ($2B)

48 active patent families

Where Poseida Therapeutics innovates Molecular biologyNucleic acidOrganic chemistryBiochemistryCell therapy

Where Poseida Therapeutics concentrates vs peers

Each axis is a top-10 topic across Poseida Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Poseida Therapeutics

An AI-synthesized read of the highest-engagement posts about Poseida Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Poseida Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles